Arcellx Inc (ACLX)
90.44
+3.22
(+3.69%)
USD |
NASDAQ |
Nov 22, 16:00
90.37
-0.07
(-0.08%)
After-Hours: 20:00
Arcellx Price to Book Value: 10.12 for Nov. 22, 2024
Price to Book Value Chart
Historical Price to Book Value Data
Date | Value |
---|---|
November 22, 2024 | 10.12 |
November 21, 2024 | 9.764 |
November 20, 2024 | 9.764 |
November 19, 2024 | 9.806 |
November 18, 2024 | 9.876 |
November 15, 2024 | 9.833 |
November 14, 2024 | 10.64 |
November 13, 2024 | 11.21 |
November 12, 2024 | 11.25 |
November 11, 2024 | 11.93 |
November 08, 2024 | 11.54 |
November 07, 2024 | 11.10 |
November 06, 2024 | 10.41 |
November 05, 2024 | 9.753 |
November 04, 2024 | 9.677 |
November 01, 2024 | 9.647 |
October 31, 2024 | 9.420 |
October 30, 2024 | 9.704 |
October 29, 2024 | 9.753 |
October 28, 2024 | 9.501 |
October 25, 2024 | 9.425 |
October 24, 2024 | 9.667 |
October 23, 2024 | 9.858 |
October 22, 2024 | 10.11 |
October 21, 2024 | 10.09 |
Date | Value |
---|---|
October 18, 2024 | 10.83 |
October 17, 2024 | 10.65 |
October 16, 2024 | 10.40 |
October 15, 2024 | 10.05 |
October 14, 2024 | 9.704 |
October 11, 2024 | 9.636 |
October 10, 2024 | 9.267 |
October 09, 2024 | 9.272 |
October 08, 2024 | 9.038 |
October 07, 2024 | 8.504 |
October 04, 2024 | 8.745 |
October 03, 2024 | 8.518 |
October 02, 2024 | 8.522 |
October 01, 2024 | 9.104 |
September 30, 2024 | 9.335 |
September 27, 2024 | 9.132 |
September 26, 2024 | 9.284 |
September 25, 2024 | 9.335 |
September 24, 2024 | 9.317 |
September 23, 2024 | 9.487 |
September 20, 2024 | 9.557 |
September 19, 2024 | 9.427 |
September 18, 2024 | 8.888 |
September 17, 2024 | 8.606 |
September 16, 2024 | 8.498 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.163
Minimum
May 18 2022
11.93
Maximum
Nov 11 2024
5.837
Average
5.920
Median
Oct 25 2023
Price to Book Value Benchmarks
Boston Scientific Corp | 6.406 |
AbbVie Inc | 51.84 |
NovaBay Pharmaceuticals Inc | 3.121 |
Palatin Technologies Inc | -- |
iBio Inc | 1.360 |
Price to Book Value Related Metrics
PS Ratio | 30.33 |
Price to Free Cash Flow | 1318.93 |
Price | 90.44 |
Earnings Yield | -0.79% |
Market Cap | 4.891B |